Related references
Note: Only part of the references are listed.Nucleoplasmic lamins define growth-regulating functions of lamina-associated polypeptide 2 alpha in progeria cells
Sandra Vidak et al.
JOURNAL OF CELL SCIENCE (2018)
Efforts to Develop KRAS Inhibitors
Matthew Holderfield
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
KRAS: Reasons for optimism in lung cancer
C. R. Lindsay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange
Chimno I. Nnadi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
The reactivity-driven biochemical mechanism of covalent KRAS(G12C) inhibitors
Rasmus Hansen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
The reactivity-driven biochemical mechanism of covalent KRAS(G12C) inhibitors
Rasmus Hansen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Differential Effector Engagement by Oncogenic KRAS
Tina L. Yuan et al.
CELL REPORTS (2018)
Personalized cancer-specific protein corona affects the therapeutic impact of nanoparticles
Claudia Corbo et al.
CANCER RESEARCH (2018)
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
Camilo E. Quevedo et al.
NATURE COMMUNICATIONS (2018)
Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
Pan-Yu Chen et al.
CANCER RESEARCH (2018)
Inhibition of K-RAS4B by a Unique Mechanism of Action: Stabilizing Membrane-Dependent Occlusion of the Effector-Binding Site
Zhenhao Fang et al.
CELL CHEMICAL BIOLOGY (2018)
Raslns: Genetically Encoded Intrabodies of Activated Ras Proteins
Mehmet Cetin et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d
Satoshi Sogabe et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
Moiez Ali et al.
NATURE COMMUNICATIONS (2017)
Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
Seung-Min Shin et al.
NATURE COMMUNICATIONS (2017)
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
Sandrine Guillard et al.
NATURE COMMUNICATIONS (2017)
Inhibition of prenylated KRAS in a lipid environment
Johanna M. Jansen et al.
PLOS ONE (2017)
Expanding the Scope of Electrophiles Capable of Targeting K-Ras Oncogenes
Lynn M. McGregor et al.
BIOCHEMISTRY (2017)
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu et al.
CELL (2017)
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Tim Wang et al.
CELL (2017)
Multivalent Small-Molecule Pan-RAS Inhibitors
Matthew E. Welsch et al.
CELL (2017)
The RAS-Effector Interaction as a Drug Target
Adam B. Keeton et al.
CANCER RESEARCH (2017)
Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
Daisuke Hashimoto et al.
PANCREAS (2016)
Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ
Srisathiyanarayanan Dharmaiah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State
Matthew P. Patricelli et al.
CANCER DISCOVERY (2016)
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling
Man-Tzu Wang et al.
CELL (2015)
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Adrienne D. Cox et al.
CLINICAL CANCER RESEARCH (2015)
K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif
Frederick D. Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Susan K. Fetics et al.
STRUCTURE (2015)
Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers
Shaun S. Sanders et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor
Sang Min Lim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
Structure Guided Design and Kinetic Analysis of Highly Potent Benzimidazole Inhibitors Targeting the PDEδ Prenyl Binding Site
Gunther Zimmermann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor
Sara Koenig McLaughlin et al.
CANCER CELL (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann et al.
NATURE (2013)
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
Qi Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
Snjezana Dogan et al.
CLINICAL CANCER RESEARCH (2012)
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
Till Maurer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An orthosteric inhibitor of the Ras-Sos interaction
Anupam Patgiri et al.
NATURE CHEMICAL BIOLOGY (2011)
K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function
B. Alvarez-Moya et al.
ONCOGENE (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
SOSI mutations are rare in human malignancies: Implications for Noonan syndrome patients
Kenneth D. Swanson et al.
GENES CHROMOSOMES & CANCER (2008)
Activated kras, but not hras or nras, may initiate tumors of endodermal origin via stem cell expansion
Margaret P. Quinlan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer
Minh D. To et al.
NATURE GENETICS (2008)
Towards complete sets of farnesylated and geranylgeranylated proteins
Sebastian Maurer-Stroh et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity
P Rodriguez-Viciana et al.
MOLECULAR CELL (2006)
PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis
TG Bivona et al.
MOLECULAR CELL (2006)
Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation
T Tanaka et al.
EMBO JOURNAL (2003)
Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling
P Villalonga et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
